Tert-butyl [4-[1-[3-(3-fluoro-4-methylsulfinylphenyl)-1,2,4-oxadiazol-5-yl]propoxy]piperidin-1-yl] carbonate
C22H30FN3O6S — CID 70376060
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl [4-[1-[3-(3-fluoro-4-methylsulfinylphenyl)-1,2,4-oxadiazol-5-yl]propoxy]piperidin-1-yl] carbonate
Tert-butyl [4-[1-[3-(3-fluoro-4-methylsulfinylphenyl)-1,2,4-oxadiazol-5-yl]propoxy]piperidin-1-yl] carbonate (PubChem CID 70376060) has the molecular formula C22H30FN3O6S and a molecular weight of 483.56 g/mol. Its IUPAC name is tert-butyl [4-[1-[3-(3-fluoro-4-methylsulfinylphenyl)-1,2,4-oxadiazol-5-yl]propoxy]piperidin-1-yl] carbonate.
Molecular Properties
| Compound Name | Tert-butyl [4-[1-[3-(3-fluoro-4-methylsulfinylphenyl)-1,2,4-oxadiazol-5-yl]propoxy]piperidin-1-yl] carbonate |
|---|---|
| PubChem CID | 70376060 |
| Molecular Formula | C22H30FN3O6S |
| Molecular Weight | 483.56 g/mol |
| Exact Mass | 483.18 |
| IUPAC Name | tert-butyl [4-[1-[3-(3-fluoro-4-methylsulfinylphenyl)-1,2,4-oxadiazol-5-yl]propoxy]piperidin-1-yl] carbonate |
| SMILES | CCC(OC1CCN(OC(=O)OC(C)(C)C)CC1)c1nc(-c2ccc(S(C)=O)c(F)c2)no1 |
| InChI | InChI=1S/C22H30FN3O6S/c1-6-17(29-15-9-11-26(12-10-15)32-21(27)30-22(2,3)4)20-24-19(25-31-20)14-7-8-18(33(5)28)16(23)13-14/h7-8,13,15,17H,6,9-12H2,1-5H3 |
| InChIKey | PNVFNSSBELGDMT-UHFFFAOYSA-N |
| XLogP | 4.41 |
| TPSA | 103.99 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 483.56 |
| LogP ≤ 5 | 4.41 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 70376060 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.